BiotechTube
Home/Kyverna Therapeutics/Matthew J. Warren
MJ

Matthew J. Warren

Chief Business Officer

Kyverna Therapeutics

Therapeutic Areas

Autoimmune DiseasesImmunology

Kyverna Therapeutics Pipeline

DrugIndicationPhase
KYV-101 (mivocabtagene autoleucel)Lupus NephritisPhase 2
KYV-102Autoimmune DiseasesPhase 1
KYV-201Autoimmune DiseasesPreclinical

Leadership Team at Kyverna Therapeutics

PM
Peter Maag
Chief Executive Officer & Chairman
DR
Dominik Rüttinger
Chief Medical Officer
JV
Jens Vogel
Chief Scientific Officer & Head of R&D
KF
Kathleen Fan
Chief Financial Officer
View full Kyverna Therapeutics profile